Streetbeat News

Products Services

BTCY

Biotricity has expanded its intellectual property portfolio by securing 14 new patents. These patents focus on a multi-biometric device platform that can function as both a patch and a watch, enhancing remote patient care in monitoring, diagnostics, and chronic disease management.

Portfolio Pulse from

March 12, 2025 | 12:30 pm

HCWC

Healthy Choice Wellness Corp. (NYSEAM: HCWC) is focusing on strategic growth by expanding revenue streams, improving operational efficiencies, investing in leadership, and enhancing customer engagement. These initiatives aim to position the company for sustainable growth in 2025.

Portfolio Pulse from

March 12, 2025 | 12:30 pm

AAAU

Jim Wyckoff, a seasoned financial journalist, provides an analysis of the gold market for March 12, focusing on key intra-day price entry levels for active traders. The article may mention AAAU, a gold ETF.

Portfolio Pulse from

March 12, 2025 | 12:15 pm

FCEL

FuelCell Energy is participating in the Innovation Agora at the 2025 CERAWeek Conference, showcasing their solid oxide fuel cell and electrolyzer products.

Portfolio Pulse from

March 12, 2025 | 12:15 pm

UBER

The article discusses whether investors should consider buying Grab stock, noting its business similarity to Uber, which recently saw a 3.30% decline in its stock price.

Portfolio Pulse from

March 12, 2025 | 12:15 pm

ORCL

Oracle's recent earnings report and management comments have significant implications for the AI industry. The video covers these insights, highlighting Oracle's role in advancing AI technology.

Portfolio Pulse from

March 12, 2025 | 12:15 pm

ADY

Adyton Resources Corporation announced that the Papua New Guinea Mineral Resources Authority visited the Wapolu project to expedite the permitting process for restarting operations at the former mine.

Portfolio Pulse from

March 12, 2025 | 12:15 pm

AMZN

Audible is launching a new well-being podcast featuring Chrissy Teigen, celebrated at The Conscious Club in Venice, California.

Portfolio Pulse from

March 12, 2025 | 12:15 pm

EBS

Emergent BioSolutions Inc. (NYSE: EBS) has announced a strategic financial investment in Swiss Rockets Ltd, the parent company of Rocketvax Ltd, to support research and development in next-generation biotechnology products.

Portfolio Pulse from

March 12, 2025 | 12:15 pm

CLNN

Clene's CNM-Au8® treatment has shown a significant survival advantage for ALS patients in a new cross-regimen analysis of the HEALEY ALS Platform Trial. This strengthens the potential of CNM-Au8® as a beneficial treatment for ALS.

Portfolio Pulse from

March 12, 2025 | 12:15 pm